Biotechnologieaktien – KI-Analyse & Ranglisten
Diese Seite wurde per KI maschinell aus dem englischen Original übersetzt; die englische Fassung ist maßgeblich. Englische Fassung lesen
Kurzantwort
Durchsuchen Sie alle Biotechnologieaktien mit KI-gestützter Analyse, MoonshotScores und Kurszielen.
Durchsuchen Sie alle Biotechnologieaktien mit KI-gestützter Analyse, MoonshotScores und Kurszielen.
Verwandte Aktien in Biotechnologie
| Unternehmen | Kurs | Änderung | Marktkapitalisierung | MoonshotScore |
|---|---|---|---|---|
| ETON Eton Pharmaceuticals, Inc. | $60.85 | -0.83% | $1.76B | — |
| EXEL Exelixis, Inc. | $64.63 | -1.82% | $16.3B | — |
| KNSA Kiniksa Pharmaceuticals, Ltd. | $93.89 | +0.38% | $7.38B | — |
| ADMA ADMA Biologics, Inc. | $13.17 | -1.27% | $2.92B | — |
| AUPH Aurinia Pharmaceuticals Inc. | $14.70 | -1.28% | $1.97B | — |
| NRIX Nurix Therapeutics, Inc. | $12.85 | -5.55% | $1.40B | — |
| UTHR United Therapeutics Corporation | $554.73 | -0.78% | $23.6B | — |
| ARGX argenx SE | $925.70 | -1.73% | $58.2B | — |
| ASND Ascendis Pharma A/S | $252.73 | -1.26% | $16.6B | — |
| HALO Halozyme Therapeutics, Inc. | $91.35 | -1.82% | $10.4B | — |
| HRMY Harmony Biosciences Holdings, Inc. | $32.59 | -1.18% | $1.91B | — |
| INVA Innoviva, Inc. | $18.41 | — | $1.31B | — |
| KRYS Krystal Biotech, Inc. | $308.89 | -2.19% | $9.15B | — |
| VCEL Vericel Corporation | $57.52 | -1.27% | $2.94B | — |
| REGN Regeneron Pharmaceuticals, Inc. | $920.69 | -0.19% | $95.2B | — |
| NBIX Neurocrine Biosciences, Inc. | $150.57 | -3.84% | $15.2B | — |
| FENC Fennec Pharmaceuticals Inc. | $13.09 | -2.68% | $462M | — |
| TECH Bio-Techne Corporation | $72.67 | -0.04% | $11.4B | — |
| TGTX TG Therapeutics, Inc. | $63.34 | -2.37% | $9.57B | — |
| CORT Corcept Therapeutics Incorporated | $63.62 | -2.09% | $6.96B | — |
| INCY Incyte Corporation | $114.63 | -1.07% | $23.4B | — |
| VRTX Vertex Pharmaceuticals Incorporated | $515.02 | -1.08% | $131B | — |
| ZVRA Zevra Therapeutics, Inc. | $8.76 | -3.42% | $521M | — |
| PLX Protalix BioTherapeutics, Inc. | $2.90 | -5.23% | $245M | — |
| ARQT Arcutis Biotherapeutics, Inc. | $26.36 | -2.98% | $3.33B | — |
| PTGX Protagonist Therapeutics, Inc. | $121.40 | -2.11% | $7.92B | — |
| VCYT Veracyte, Inc. | $25.13 | +0.36% | $2.03B | — |
| NVO Novo Nordisk A/S | $37.82 | -2.70% | $167B | — |
| RIGL Rigel Pharmaceuticals, Inc. | $40.09 | -2.67% | $755M | — |
| EWTX Edgewise Therapeutics, Inc. | $39.91 | -3.07% | $4.37B | — |
| ICCC ImmuCell Corporation | $10.92 | -2.41% | $99.3M | — |
| RLYB Rallybio Corporation | $15.47 | -0.32% | $83.3M | — |
| CAI Caris Life Sciences, Inc. | $17.58 | -5.18% | $5.04B | — |
| ANAB AnaptysBio, Inc. | $46.63 | -1.62% | $1.39B | — |
| RPRX Royalty Pharma plc | $68.45 | +1.08% | $30.5B | — |
| ELVN Enliven Therapeutics, Inc. | $46.53 | +0.26% | $3.42B | — |
| ALNY Alnylam Pharmaceuticals, Inc. | $143.82 | -2.71% | $19.3B | — |
| GMAB Genmab A/S | $50.60 | -1.46% | $31.2B | — |
| LGND Ligand Pharmaceuticals Incorporated | $286.85 | -0.03% | $5.74B | — |
| ORMP Oramed Pharmaceuticals Inc. | $3.57 | -3.25% | $155M | — |
| CGEN Compugen Ltd. | $1.84 | -2.13% | $174M | — |
| LBRX LB Pharmaceuticals Inc | $38.85 | -2.97% | $1.26B | — |
| PHAR Pharming Group N.V. | $11.54 | -5.10% | $817M | — |
| VOR Vor Biopharma, Inc. | $19.19 | +3.62% | $1.18B | — |
| ACAD ACADIA Pharmaceuticals Inc. | $17.11 | -2.73% | $2.96B | — |
| CLYM Climb Bio, Inc. | $9.19 | -0.97% | $540M | — |
| ERAS Erasca, Inc. | $13.61 | -4.29% | $4.78B | — |
| ORKA Oruka Therapeutics, Inc. | $95.81 | -1.80% | $6.50B | — |
| MANE Veradermics, Incorporated | $119.52 | -3.92% | $5.04B | — |
| AMLX Amylyx Pharmaceuticals, Inc. | $26.02 | -0.69% | $3.35B | — |
KI-Score von Stock Expert AI · Kursdaten: FMP / Yahoo Finance